Sleep | Page 29 of 54 | SpiritIndia.com

COPD :: Inhaled corticosteroids reduce death in patients with copd

Prescription sleep aids may do little to improve the use of continuous positive airway pressure (CPAP) among patients with obstructive sleep apnea (OSA). A new study published in the November issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), finds that patients with OSA who were given prescription sleep aids were no more likely to use their CPAP machines than patients with OSA taking a placebo.

New analysis shows Kadian alleviates chronic moderate-to-severe non-malignant neck pain

Data presented this week at the American Academy of Physical Medicine and Rehabilitation meeting, demonstrated that Kadian improved sleep and overall quality of life in patients with moderate-to-severe chronic neck pain who had inadequate relief on previous analgesic regimens. Kadian is an extended-release formulation of morphine sulfate.

Asthma :: New asthma book updates treatment – Australia

The latest medical and clinical research on treatment and diagnosis of asthma will be made available free of charge to doctors, pharmacists and other professionals who deal with asthma patients, via a new handbook.

Brain :: Speak, memory – Research challenges theory of memory storage

During sleep, freshly minted memories move from the hippocampus, part of the “old” brain, to the neocortex, or “new” brain, for long-term storage. This has been the reigning theory for decades. Brown University research provides the strongest proof yet of this interaction between the old and new brains — and offers surprising evidence that challenges critical details of this theory of learning and memory. Results appear in Nature Neuroscience.

Children’s sleep difficulties: Reports differ from children to parents

Elementary school-aged children report that they have sleep difficulties more often than their parents report think they do. A sample of 300 pairs of eight-year-old twins was studied to examine the genetic and environmental influences on sleep. The research suggests several explanations for the discrepancy between child and parent reported sleep difficulties in children. Overall, the findings reflect that both genetic and environmental influences are factors in a range of sleep problems.

Apnea :: Research questions use of sleep meds for patients with apnea

New research reported in the journal CHEST shows that prescription sleep aids may do little to improve the use of continuous positive airway pressure among patients with obstructive sleep apnea. The study found that patients with OSA who were given prescription sleep aids were no more likely to use their CPAP machines than patients with OSA taking a placebo.

Research Findings in Allergy-Immunology Unveiled

Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on allergic rhinitis and ocular allergies.

Allergists Explore Rising Prevalence and Unmet Needs Attributed to Allergic Rhinitis

As the prevalence of allergic rhinitis appears to be rising, there are increasing concerns about its impact on health, sleep, work and school performance, as well as unmet patient needs regarding its treatment according to experts presenting new data at the Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).

Restless Legs Syndrome :: Boehringer Ingelheim?s pramipexole for the treatment of Restless Legs Syndrome RLS

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved pramipexole, a non-ergot dopamine agonist, for the treatment of moderate to severe primary Restless Legs Syndrome (RLS).1 This is an important milestone for pramipexole (Mirapexin? / Sifrol? / Mirapex?), which was already approved throughout the European Union in April 2006 for this second indication.

ADHD :: Study Evaluates Two Medications for ADHD

University of Illinois at Chicago researchers are comparing two drugs commonly used to treat attention deficit hyperactivity disorder to determine if genetic factors predict which children will respond to either or both drugs.